Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Science (New York, N.Y.)|March 16, 2019
Ushering in the next generation of precision trials for pediatric cancerSteven G DuBois, Laura B Corson, Kimberly Stegmaier, et al.Molecular and Cellular Biology|May 4, 2004
Characterization of mouse Rsk4 as an inhibitor of fibroblast growth factor-RAS-extracellular signal-regulated kinase signalingAndrea Pomrehn Myers, Laura B Corson, Janet Rossant, et al.Cell Cycle (Georgetown, Tex.)|January 18, 2013
A high-content cellular senescence screen identifies candidate tumor suppressors, including EPHA3Jenni Lahtela, Laura B Corson, Annabrita Hemmes, et al.Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Identification of 3,6-disubstituted dihydropyrones as inhibitors of human lactate dehydrogenaseBenjamin P Fauber, Peter S Dragovich, Jinhua Chen, et al.Bioorganic & Medicinal Chemistry Letters|September 10, 2013
Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenaseBenjamin P Fauber, Peter S Dragovich, Jinhua Chen, et al.Bioorganic & Medicinal Chemistry Letters|May 1, 2013
Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenasePeter S Dragovich, Benjamin P Fauber, Laura B Corson, et al.Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenaseSharada Labadie, Peter S Dragovich, Jinhua Chen, et al.Bioorganic & Medicinal Chemistry Letters|January 22, 2022
Structure-based optimization of hydroxylactam as potent, cell-active inhibitors of lactate dehydrogenaseBinQing Wei, Kirk Robarge, Sharada S Labadie, et al.Bioorganic & Medicinal Chemistry Letters|July 20, 2014
Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenasePeter S Dragovich, Benjamin P Fauber, Jason Boggs, et al.ACS Medicinal Chemistry Letters|October 25, 2016
Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in MiceHans E Purkey, Kirk Robarge, Jinhua Chen, et al.Pageof 2